The following articles provide more information on the use — and misuse — of psychiatric drugs on children and teens.

School calls child services on parents who take child off of Ritalin

(Reprinted with permission of the Times Union of Albany, New York)  Ritalin use splits parents, school By RICK KARLIN , Staff writer Times Union, Albany, NY Sunday, May 7, 2000 Berne — District marks parents as alleged child abusers for wanting to take their 7-year-old son off the medication Like thousands of children, 7-year-old Kyle […]

Read More

Dr. Breggin Testifies Before US Congress Re: Ritalin and ADHD

Peter R. Breggin M.D. Testimony September 29, 2000 Before the Subcommittee on Oversight and Investigations Committee on Education and the Workforce U.S. House of Representatives I appear today as Director of the International Center for the Study of Psychiatry and Psychology (ICSPP), and also on my own behalf as a practicing psychiatrist and a parent. […]

Read More

U.S. Attention Deficit On Legal Drug Risks

  By Arianna Huffington December 7, 1998 (Thanks to Arianna Huffington for permission to reprint) Ten days ago (November 27, 1998) the Food and Drug Administration issued new rules that require drug companies to study a lot more thoroughly the safety and effectiveness of drugs for children. Staggering though it is to believe, many drugs regularly […]

Read More

Pregnant Mothers Should Not Take SSRI Antidepressants

On June 28, 2007 more than 250 headlines around the world promised that SSRI antidepressants (such as Prozac, Paxil, Zoloft, and Celexa) are safe for pregnant mothers and their developing babies. “Mom’s Antidepressant Use Poses Little Danger to Baby,” heralded the Atlanta Journal Constitution. “Antidepressants pose low birth defect risk,” claimed Boston Globe. The New York Times ran with the Associated Press’s article titled “Antidepressants Not Big Risk for Defects.” The Wall Street Journal’s coverage was titled “Reassurance on Antidepressants in Pregnancy.” The day before the news stories broke, the Centers for Disease Control spun the news in advance with a press release headlined, “New Study Finds Few Risks of Birth Defects from Antidepressant Use During Pregnancy” (CDC Division of Media, 2007).

Read More

Fenfluramine damage to the brain and mind

RECENT FDA DECISION HIGHLIGHTS ETHICAL ISSUES IN DRUG RESEARCH ON CHILDREN by Peter R. Breggin, M.D. April 21, 1998 The FDA has put the interests of drug companies and the psychiatric research establishment ahead of those of America’s children. It is time for the public and concerned professionals to take a stand against unethical pharmacological […]

Read More

The Hazards of Treating “Attention-Deficit/Hyperactivity Disorder” with Methylphenidate (Ritalin) (1995)

Originally published in The Journal of College Student Psychotherapy, Vol. 10(2) 1995, pp. 55-72 by Peter R. Breggin, M.D. and Ginger Ross Breggin ABSTRACT. The criteria for Attention-Deficit/Hyperactivity Disorder focus on behaviors that adults find frustrating and disruptive. Conflicts between children and adults are redefined as diseases or disorders within the children. Treatment with stimulant […]

Read More